XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in XBiotech Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −2 vs. Q4 2022
- Shares held
- 2.45M
- −312.0K (−11.3%) vs. Q4 2022
- Total value
- $8.61M
- −$1.07M (−11.0%) vs. Q4 2022
- New holders
- 3
- 8 more added
- Sold out
- 5
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 38 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 85 | $0 | 0.00% | +85 | New |
| Advisor Group Holdings, Inc. | 50 | $173 | 0.00% | −300−85.7% | Reduced |
| Wells Fargo & Company | 122 | $421 | 0.00% | +2+1.7% | Added |
| TD Waterhouse Canada Inc. | 200 | $928 | 0.00% | +200 | New |
| Tower Research Capital LLC (TRC) | 236 | $1.00K | 0.00% | +65+38.0% | Added |
| Financial Connections Group, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| McIlrath & Eck, LLC | 753 | $2.60K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,473 | $5.08K | 0.00% | +1,073+268.3% | Added |
| Royal Bank of Canada | 2,453 | $8.00K | 0.00% | +453+22.7% | Added |
| UBS Group AG | 5,033 | $17.4K | 0.00% | −864−14.7% | Reduced |
| LGT Fund Management Co Ltd. | 10,000 | $34.5K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,477 | $36.1K | 0.00% | 00.0% | Unchanged |
| Synovus Financial Corp | 11,796 | $40.7K | 0.00% | 00.0% | Unchanged |
| Thomasville National Bank | 13,350 | $46.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 14,110 | $48.7K | 0.00% | −4,624−24.7% | Reduced |
| Price T Rowe Associates Inc | 17,600 | $61.0K | 0.00% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 19,700 | $68.0K | 0.00% | −5,300−21.2% | Reduced |
| Citadel Advisors LLC | 20,374 | $70.3K | 0.00% | +8,649+73.8% | Added |
| FMR LLC | 20,440 | $70.5K | 0.00% | +160+0.8% | Added |
| Susquehanna Fundamental Investments, LLC | 20,863 | $72.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 24,150 | $82.0K | 0.00% | −13,426−35.7% | Reduced |
| Susquehanna International Group, LLP | 38,163 | $131.7K | 0.00% | +38,163 | New |
| Millennium Management LLC | 45,651 | $157.0K | 0.00% | −6,593−12.6% | Reduced |
| Two Sigma Advisers, LP | 47,900 | $165.3K | 0.00% | −11,700−19.6% | Reduced |
| Northern Trust Corp | 47,919 | $165.3K | 0.00% | +3,232+7.2% | Added |
| Man Group plc | – | $173.2K | 0.00% | – | – |
| Renaissance Technologies LLC | 52,495 | $181.0K | 0.00% | −48,973−48.3% | Reduced |
| Two Sigma Investments, LP | 54,937 | $189.5K | 0.00% | −11,099−16.8% | Reduced |
| Bank of New York Mellon Corp | 55,693 | $192.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 57,295 | $197.7K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 57,916 | $199.8K | 0.00% | −7,110−10.9% | Reduced |
| Dimensional Fund Advisors LP | 75,126 | $259.0K | 0.00% | −7,272−8.8% | Reduced |
| Morgan Stanley | 87,307 | $301.2K | 0.00% | −11,050−11.2% | Reduced |
| Bridgeway Capital Management, LLC | 114,340 | $394.5K | 0.01% | −9,060−7.3% | Reduced |
| Geode Capital Management, LLC | 155,083 | $535.0K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 245,270 | $846.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 262,196 | $904.6K | 0.00% | +995+0.4% | Added |
| Vanguard Group Inc | 854,469 | $2.95M | 0.00% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −137,174−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,052−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,279−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −12,985−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |